Antidiabetic Drugs from Natural Resources
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 5549
Special Issue Editor
Special Issue Information
Dear Colleagues,
Diabetes mellitus and its complications are one of the major health challenges of our time. Currently, more than 400 million adults are affected, a number that is expected to increase to 600 million people within the next two decades. Type 2 diabetes mellitus, or non-insulin dependent diabetes mellitus, is the most common type and its initial stages are treated with oral antidiabetics. Though antihyperglycemic agents with different mechanisms of action are commercially available, their adverse events and hepato-renal toxicity are pronounced. Thus, the discovery of new and safer medicines is urgently warranted.
Natural drug products have always been an important source of bioactives and drugs derived from nature still account for half of today’s approved therapeutics. This Special Issue, “Antidiabetic Drugs from Natural Resources”, is dedicated to the discovery of new antidiabetic lead compounds from nature. Research articles and reviews dealing with novel antidiabetic activities of natural products and/or natural sources of antidiabetics are therefore very welcome. Additionally, the evaluation of extracts and herbal preparations used for the treatment of diabetes mellitus by modern analytical techniques will be considered.
Dr. Serhat Sezai Çiçek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes mellitus
- natural products
- α-glucosidase
- PPARγ
- DPP IV
- 11β-HSD1
- SGLT2
- PTP1B
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
